FR2279414A1 - Composition pharmaceutique comprenant des composes de magnesium et de potassium - Google Patents

Composition pharmaceutique comprenant des composes de magnesium et de potassium

Info

Publication number
FR2279414A1
FR2279414A1 FR7426121A FR7426121A FR2279414A1 FR 2279414 A1 FR2279414 A1 FR 2279414A1 FR 7426121 A FR7426121 A FR 7426121A FR 7426121 A FR7426121 A FR 7426121A FR 2279414 A1 FR2279414 A1 FR 2279414A1
Authority
FR
France
Prior art keywords
magnesium
pharmaceutical composition
composition consisting
potassium compounds
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7426121A
Other languages
English (en)
French (fr)
Other versions
FR2279414B1 (ref
Inventor
Maurice Bloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB121473A priority Critical patent/GB1422193A/en
Priority to AU70802/74A priority patent/AU487061B2/en
Priority to BE146571A priority patent/BE817670A/xx
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to FR7426121A priority patent/FR2279414A1/fr
Publication of FR2279414A1 publication Critical patent/FR2279414A1/fr
Application granted granted Critical
Publication of FR2279414B1 publication Critical patent/FR2279414B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7426121A 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium Granted FR2279414A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB121473A GB1422193A (en) 1974-07-26 1974-04-09 Pharmaceutical compositions
AU70802/74A AU487061B2 (en) 1974-07-26 1974-07-03 Pharmaceutical compositions
BE146571A BE817670A (fr) 1974-07-26 1974-07-15 Compositions pharmaceutiques comprenant des composes de magnesium et de potassium.
FR7426121A FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7426121A FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Publications (2)

Publication Number Publication Date
FR2279414A1 true FR2279414A1 (fr) 1976-02-20
FR2279414B1 FR2279414B1 (ref) 1978-07-21

Family

ID=9141793

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426121A Granted FR2279414A1 (fr) 1974-07-26 1974-07-26 Composition pharmaceutique comprenant des composes de magnesium et de potassium

Country Status (4)

Country Link
AU (1) AU487061B2 (ref)
BE (1) BE817670A (ref)
FR (1) FR2279414A1 (ref)
GB (1) GB1422193A (ref)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484254A1 (fr) * 1980-06-13 1981-12-18 Robins Co Inc A H Compositions pharmaceutiq
EP0150792A3 (en) * 1984-01-27 1987-03-04 Algina Aktiengesellschaft Drugs and the use of poorly soluble compounds of calcium and/or magnesium as drugs
FR2620334A1 (fr) * 1987-09-11 1989-03-17 Ciba Geigy Ag Composition pour l'administration orale contenant du magnesium et du potassium

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI60107C (fi) * 1978-02-24 1982-12-13 Suomen Laeaeketehdas Oy Salco Som krydda eller som konserveringsmedel foer livsmedel anvaendbar bordssaltprodukt
GB8308126D0 (en) * 1983-03-24 1983-05-05 Bloch M Pharmaceutical compositions
US4954349A (en) * 1987-09-11 1990-09-04 Ciba-Geigy Corporation Oral magnesium and potassium compositions and use
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
EP1661575A1 (en) * 2004-11-26 2006-05-31 ZAMBON GROUP S.p.A. Use of magnesium in the treatment of disorders related to hormonal variations in women
US8178133B2 (en) 2007-03-22 2012-05-15 Magceutics, Inc. Magnesium compositions and uses thereof
US8377473B2 (en) 2009-07-01 2013-02-19 Magceutics, Inc. Slow release magnesium composition and uses thereof
CN116421580B (zh) * 2023-04-21 2026-02-06 杭州高成生物营养技术有限公司 柠檬酸镁缓释小丸及其制备方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2484254A1 (fr) * 1980-06-13 1981-12-18 Robins Co Inc A H Compositions pharmaceutiq
EP0150792A3 (en) * 1984-01-27 1987-03-04 Algina Aktiengesellschaft Drugs and the use of poorly soluble compounds of calcium and/or magnesium as drugs
FR2620334A1 (fr) * 1987-09-11 1989-03-17 Ciba Geigy Ag Composition pour l'administration orale contenant du magnesium et du potassium
BE1001842A3 (fr) * 1987-09-11 1990-03-20 Ciba Geigy Ag Composition orale a base de potassium et de magnesium et son utilisation.

Also Published As

Publication number Publication date
FR2279414B1 (ref) 1978-07-21
AU487061B2 (en) 1976-01-08
GB1422193A (en) 1976-01-21
AU7080274A (en) 1976-01-08
BE817670A (fr) 1975-01-15

Similar Documents

Publication Publication Date Title
BE817126A (fr) Composition pharmaceutique fibrinolytique
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
IL48637A0 (en) 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted omega-pentanorprostaglandins and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
FR2279414A1 (fr) Composition pharmaceutique comprenant des composes de magnesium et de potassium
FR2287223A1 (fr) Composition pharmaceutique
FR2287215A1 (fr) Composition de comprimes
FR2286655A1 (fr) Composition parfumee solide comprenant des ethers alcoyliques de diethylene glycol et son procede de preparation
IL47329A (en) Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL47929A (en) Phenylnona-2,4,6,8-tetraenoic acid -8,6,4,2-derivatives,their manufacture and pharmaceutical compositions containing them
FR2290196A1 (fr) Composition pharmaceutique
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
FR2280679A1 (fr) Composition de polyesters
JPS51142094A (en) Iodineecontained product and pharmaceutical composition containing thereof
IL44774A0 (en) Pharmaceutical composition containing salicylates
FR2326189A2 (fr) Composition pharmaceutique
IL47826A (en) 7-aminoalkoxy-chroman and-tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
AU7810975A (en) Application of slag-forming substances
GB1519762A (en) Cinnamamides their preparation and pharmaceutical compositions containing them
JPS51125383A (en) Production of thiazolinone and pharmaceutical composition containing the same
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
IL50945A0 (en) Novel cephalosporins their preparation and pharmaceutical compositions containing them
FR2320731A1 (fr) Composition pharmaceutique
BE819436A (fr) Composition pharmaceutique renfermant des pyridylthiourees.
IL47448A0 (en) Pharmaceutical compositions containing rafoxanide and their use

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse